Skip to main content
TipRanks
Go Ultimate75% OFF

PharmGen Science, Inc. (004720) Ratios

PharmGen Science, Inc. Ratios

KR:004720's free cash flow for Q3 2026 was ₩5.97B. For the 2026 fiscal year, KR:004720's free cash flow was decreased by ₩-26.26M and operating cash flow was ₩6.00B. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio2.851.691.511.031.09
Quick Ratio2.011.211.180.730.87
Cash Ratio0.650.580.580.280.47
Solvency Ratio-2.280.070.090.670.38
Operating Cash Flow Ratio0.160.040.09-0.020.11
Short-Term Operating Cash Flow Coverage0.970.060.15-0.030.17
Net Current Asset Valueâ‚© 46.96Bâ‚© -3.31Bâ‚© -12.38Bâ‚© -39.74Bâ‚© -16.01B
Leverage Ratios
Debt-to-Assets Ratio0.030.110.110.120.22
Debt-to-Equity Ratio0.040.160.170.190.38
Debt-to-Capital Ratio0.040.140.140.160.27
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.341.461.471.531.74
Debt Service Coverage Ratio6.530.300.27-0.22-0.20
Interest Coverage Ratio4.302.562.142.66-2.87
Debt to Market Cap0.060.520.360.370.30
Interest Debt Per Share336.622379.022593.822760.863379.13
Net Debt to EBITDA-1.510.100.081.87-56.48
Profitability Margins
Gross Profit Margin63.05%63.07%57.68%53.87%55.34%
EBIT Margin3.46%3.59%5.47%4.91%-3.09%
EBITDA Margin6.09%6.30%8.02%7.14%-0.23%
Operating Profit Margin3.46%6.21%5.47%6.17%-4.49%
Pretax Profit Margin-87.31%0.59%4.79%59.60%38.18%
Net Profit Margin-67.39%1.63%3.43%46.42%29.55%
Continuous Operations Profit Margin-67.39%1.63%3.65%46.42%29.50%
Net Income Per EBT77.19%274.35%71.67%77.88%77.39%
EBT Per EBIT-2524.01%9.56%87.56%965.53%-849.54%
Return on Assets (ROA)-59.69%0.77%1.70%22.07%14.74%
Return on Equity (ROE)-79.73%1.12%2.51%33.82%25.58%
Return on Capital Employed (ROCE)3.70%3.57%3.35%3.74%-3.31%
Return on Invested Capital (ROIC)2.76%3.16%2.07%2.52%-1.94%
Return on Tangible Assets-61.84%0.78%1.74%22.51%15.04%
Earnings Yield-127.86%3.76%5.57%66.94%21.01%
Efficiency Ratios
Receivables Turnover3.904.324.685.385.45
Payables Turnover24.679.5514.5014.1010.89
Inventory Turnover2.251.993.413.333.22
Fixed Asset Turnover4.534.414.043.563.15
Asset Turnover0.890.470.500.480.50
Working Capital Turnover Ratio3.214.429.6735.055.05
Cash Conversion Cycle241.25230.07159.89151.48146.75
Days of Sales Outstanding93.5484.5277.9567.8066.99
Days of Inventory Outstanding162.51183.76107.12109.56113.26
Days of Payables Outstanding14.7938.2125.1725.8933.51
Operating Cycle256.04268.28185.07177.36180.26
Cash Flow Ratios
Operating Cash Flow Per Share242.40131.47334.09-82.58528.92
Free Cash Flow Per Share175.69-22.01131.89-850.24-1782.04
Dividend Paid and CapEx Coverage Ratio3.630.861.65-0.110.23
Capital Expenditure Coverage Ratio3.630.861.65-0.110.23
Operating Cash Flow Coverage Ratio0.890.060.14-0.030.16
Operating Cash Flow to Sales Ratio0.030.010.03-0.010.07
Free Cash Flow Yield4.23%-0.54%2.09%-12.65%-16.97%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.7826.5517.961.494.76
Price-to-Sales (P/S) Ratio0.530.430.620.691.41
Price-to-Book (P/B) Ratio0.620.300.450.511.22
Price-to-Free Cash Flow (P/FCF) Ratio23.65-185.7947.92-7.90-5.89
Price-to-Operating Cash Flow Ratio17.1431.1118.92-81.3819.85
Price-to-Earnings Growth (PEG) Ratio0.00-0.45-0.200.010.02
Enterprise Value Multiple7.156.987.7711.57-664.59
Enterprise Value75.34B75.25B103.95B124.80B168.88B
EV to EBITDA7.156.987.7711.57-664.59
EV to Sales0.440.440.620.831.54
EV to Free Cash Flow19.53-188.4748.41-9.42-6.44
EV to Operating Cash Flow14.1631.5619.11-97.0321.70
Tangible Book Value Per Share6353.9713359.8713990.4812901.328323.58
Shareholders’ Equity Per Share6663.8113753.8214018.5113298.538625.39
Tax and Other Ratios
Effective Tax Rate0.23-1.740.280.220.23
Revenue Per Share7883.069444.5610244.409690.587465.25
Net Income Per Share-5312.73153.88351.804498.212206.02
Tax Burden0.772.740.720.780.77
Interest Burden-25.240.170.8812.14-12.35
Research & Development to Revenue0.030.030.030.020.02
SG&A to Revenue0.470.420.490.320.35
Stock-Based Compensation to Revenue0.000.000.000.000.04
Income Quality-0.052.340.95-0.010.19

Currency in KRW